Blackburn TP - Search Results

1

Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells.

Hope AG, Peters JA, Brown AM, Lambert JJ, Blackburn TP. Hope AG, et al. Among authors: blackburn tp. Br J Pharmacol. 1996 Jul;118(5):1237-45. doi: 10.1111/j.1476-5381.1996.tb15529.x. Br J Pharmacol. 1996. PMID: 8818349 Free PMC article.

2

Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytes.

Downie DL, Hope AG, Lambert JJ, Peters JA, Blackburn TP, Jones BJ. Downie DL, et al. Among authors: blackburn tp. Neuropharmacology. 1994 Mar-Apr;33(3-4):473-82. doi: 10.1016/0028-3908(94)90078-7. Neuropharmacology. 1994. PMID: 7984286

3

Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.

Steward LJ, Ge J, Bentley KR, Barber PC, Hope AG, Lambert JJ, Peters JA, Blackburn TP, Barnes NM. Steward LJ, et al. Among authors: blackburn tp. Br J Pharmacol. 1995 Sep;116(2):1781-8. doi: 10.1111/j.1476-5381.1995.tb16663.x. Br J Pharmacol. 1995. PMID: 8528560 Free PMC article.

4

Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.

Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ, Blackburn TP. Belelli D, et al. Among authors: blackburn tp. Mol Pharmacol. 1995 Dec;48(6):1054-62. Mol Pharmacol. 1995. PMID: 8848005

5

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP. Kennett GA, et al. Among authors: blackburn tp. Neuropharmacology. 1997 Apr-May;36(4-5):609-20. doi: 10.1016/s0028-3908(97)00038-5. Neuropharmacology. 1997. PMID: 9225286

6

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.

Reavill C, Kettle A, Holland V, Riley G, Blackburn TP. Reavill C, et al. Among authors: blackburn tp. Br J Pharmacol. 1999 Feb;126(3):572-4. doi: 10.1038/sj.bjp.0702350. Br J Pharmacol. 1999. PMID: 10188965 Free PMC article.

7

BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.

Newberry NR, Watkins CJ, Sprosen TS, Blackburn TP, Grahame-Smith DG, Leslie RA. Newberry NR, et al. Among authors: blackburn tp. Neuropharmacology. 1993 Aug;32(8):729-35. doi: 10.1016/0028-3908(93)90180-b. Neuropharmacology. 1993. PMID: 8413836

8

Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle.

Baxter GS, Murphy OE, Blackburn TP. Baxter GS, et al. Among authors: blackburn tp. Br J Pharmacol. 1994 May;112(1):323-31. doi: 10.1111/j.1476-5381.1994.tb13072.x. Br J Pharmacol. 1994. PMID: 8032658 Free PMC article.

9

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP. Kennett GA, et al. Among authors: blackburn tp. Br J Pharmacol. 1994 Mar;111(3):797-802. doi: 10.1111/j.1476-5381.1994.tb14808.x. Br J Pharmacol. 1994. PMID: 7912626 Free PMC article.

10

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.

Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP. Kennett GA, et al. Among authors: blackburn tp. Br J Pharmacol. 1996 Feb;117(3):427-434. doi: 10.1111/j.1476-5381.1996.tb15208.x. Br J Pharmacol. 1996. PMID: 8821530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page